Condition ›

Multiple sclerosis

MS treatment, rehab and research.

  • Vitamic C may lower MS risk, study suggests
    Multiple sclerosis7 Aug

    Vitamin C supplements are linked to a lower risk of developing MS, particularly among people with a higher genetic predisposition, a study suggests. The apparent benefit was seen in people with a genetic predisposition to the condition. Researchers stressed that further work is needed to confirm the findings.   MS is marked by [...]

  • Damage to grey matter linked to worsening MS disability – study
    Multiple sclerosis6 Aug

    Grey matter damage is linked to a higher risk of worsening disability, cognitive impairment and death in people with multiple sclerosis (MS), a study suggests. The damage was more consistently linked to long-term outcomes than damage to white matter, the other main type of brain tissue. The findings offer new insight into how MRI scans [...]

  • Blood test could track ‘hidden’ progression of multiple sclerosis, study finds
    Multiple sclerosis5 Aug

    Scientists have identified a blood marker that could help doctors track the slow, silent progression of multiple sclerosis (MS) and monitor whether treatments are working - even in patients who are not experiencing relapses. The discovery, led by researchers at the University of Basel in Switzerland, focuses on a protein called glial fibrillary acidic protein [...]

  • Property firm takes on fitness challenge for MS Society
    Multiple sclerosis3 Aug

    Four Xenia Property Group employees completed a charity fitness challenge in Manchester to support the MS Society. Head of lettings Jennifer Brown, senior lettings negotiator Liam Lowe, senior estates manager Jae Manwaring and marketing coordinator Kirsty Johnston took part in the first DEKA IGNITE team event at Manchester Central. The challenge featured 10 running and [...]

  • AI project aims to advance personalised MS care
    Multiple sclerosis30 Jul

    An eight-year £2.72m AI project aims to improve personalised MS care by learning from information already collected in hospitals. The Wellcome-funded Data-driven Representation Learning for Equitable, Personalised Care in Multiple Sclerosis project, known as DreaMS, will develop AI tools to make better use of decades of existing hospital data.   The project will [...]

  • Study reveals diets with MS cognitive benefits
    Multiple sclerosis29 Jul

    Certain diets may support cognition in people with multiple sclerosis, although the evidence remains too limited for firm recommendations. Studies of the low-fat Swank and Wahls diets reported improvements in processing speed and self-perceived cognitive function. Evidence for the Mediterranean diet was mixed, while small studies suggested possible benefits from ketogenic diets and time-restricted eating. [...]

  • Trouble retrieving the right words with MS linked to cognition, study suggests
    Multiple sclerosis13 Jul

    Word-finding problems affect one in four people with MS and are linked to cognition rather than fatigue or depression, a study suggests. People with cognitive impairment were nearly five times more likely to experience difficulties retrieving words than those without cognitive impairment. The symptom was not associated with fatigue or depression.   “Findings [...]

  • Brain legion breakthrough could transform MS
    Multiple sclerosis8 Jul

    AI has revealed previously undetectable brain lesions in people with MS, in research that could change how the condition is monitored. Multiple sclerosis, commonly known as MS, is a debilitating condition in which the immune system mistakenly attacks the nervous system. It affects around 150,000 people in the UK. It can cause fatigue, vision problems, [...]

  • MS impacts daily life far beyond physical symptoms, study finds
    Multiple sclerosis7 Jul

    MS affects social life and work for many people, while finances and education are also affected, a nationwide study has found. More than half of participants said the condition affected their social lives, while almost half reported an impact on their work. The findings suggest the effects of the neurological condition extend beyond physical symptoms [...]

  • Final patient dosed in nasal MS therapy trial
    Multiple sclerosis6 Jul

    The final patient has begun dosing in a trial of a nasal therapy for non-active secondary progressive multiple sclerosis. The phase 2a study is evaluating the safety, tolerability and efficacy of foralumab compared with a placebo, an inactive treatment. Headline results are expected later this year and are planned for presentation at the joint ACTRIMS-ECTRIMS [...]